Showing results (11-20 of 2,276) with videos related to
Sort By:
Pageof 228
Diabetes & Metabolism|May 29, 2012
Decreased fat oxidation during exercise in severe obstructive sleep apnoea syndromeM Desplan, J-F Brun, F Pillard, et al.Diabetes & Metabolism|March 26, 2013
Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetesH Wilmot-Roussel, D-J Lévy, C Carette, et al.Diabetes & Metabolism|March 26, 2013
MRI measurement of liver fat content predicts the metabolic syndromeP-H Ducluzeau, J Boursier, S Bertrais, et al.Diabetes & Metabolism|September 5, 2015
Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetesS P Choukem, E Sobngwi, J P Garnier, et al.Diabetes & Metabolism|January 17, 2016
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: lessons from the 4B and Get-Goal DUO 2 trialsF Porcellati, P Lucidi, G B Bolli, et al.Diabetes & Metabolism|May 15, 2016
Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitusY Hu, J Liu, H Zhang, et al.Diabetes & Metabolism|February 11, 2025
Continuous glucose monitoring‑derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetesQin Zhang, Shucai Xiao, Fang Zou, et al.Diabetes & Metabolism|February 4, 2025
Early use of hybrid closed-loop following total pancreaticoduodenectomyAlice Larroumet, Arthur Marichez, Marion Camoin, et al.Diabetes & Metabolism|January 16, 2025
Weight loss therapy and addiction: Increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonistsAndré J ScheenDiabetes & Metabolism|December 8, 2024
Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complicationsVincent Rigalleau, Yann Pucheux, Thierry Couffinhal, et al.Pageof 228